Tricida Receives $30,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3b8e368e-f1f4-47cd-ae17-d638dc87effa - Date
3/5/2015 - Company Name
Tricida - Mailing Address
7000 Shoreline Court South San Francisco, CA 94080 USA - Company Description
Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease. - Website
http://www.tricida.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series B - Proceeds Purposes
Tricida’s clinical lead candidate, TRC101, is on track for an IND submission later this year. I am excited by our rapid progress that has allowed us to advance TRC101 from discovery into development in record time. - M&A Terms
- Venture Investor
- Venture Investor
